Xconomy

JULY 10, 2019

Eight years after San Diego biotech Prometheus Laboratories was acquired by Nestlé Health Science , the diagnostic business has been sold again, this time to a little-known biotech called Precision IBD that plans to lay off approximately a quarter of Prometheus’s workforce.

Layoffs 91

Layoffs San Diego Develop Development 91

Xconomy

NOVEMBER 4, 2019

An experimental Halozyme Therapeutics treatment for pancreatic cancer has failed a pivotal study, and the company is stopping further development of the drug and closing its oncology operations as part of a corporate restructuring.

San Diego 40

San Diego Study Develop Development 40

Xconomy

OCTOBER 7, 2016

. —Sarepta Pharmaceuticals (NASDAQ: SRPT ) struck a second deal in as many weeks to develop combination therapies for Duchenne muscular dystrophy. —Ra Pharma filed for an IPO , looking for more cash as it prepares to take on rare disease drug developer Alexion Pharmaceuticals (NASDAQ: ALXN ).

Technical Review 77

Technical Review Study Layoffs San Diego 77

Xconomy

JULY 1, 2016

If you want fireworks this weekend, you can either celebrate the 4th of July or watch the latest post-Brexit political developments in Britain. AstraZeneca’s olaparib (Lynparza) became the first approved PARP drug in 2014, and several others are being developed, including talazoparib from San Francisco’s Medivation (NASDAQ: MDVN ).

Buzzfeed 59

Buzzfeed News Pricing IBM 59

Xconomy

JULY 15, 2016

Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. The week started on a reflective note. And then the news flowed, from a fast reprieve for Juno Therapeutics to no mercy for Elizabeth Holmes. —In other Merck news, U.K.-based

News 40

News Technical Review San Diego Startup 40

Xconomy

JULY 1, 2016

Layoffs Reflect New Turbulence at High-Flying 3D Robotics. The Xconversation: Vaccine Developer Meets Energy Innovator. Amid Leadership Changes, NY Biotech Braces for Its Pivotal Moment. Ben Fidler chronicles the rise of New York’s life sciences scene, from startups and investors to universities and nonprofits.

Artificial Inteligence 40

Artificial Inteligence Layoffs Report Startup 40

Xconomy

JANUARY 25, 2019

After guiding the CRISPR-Cas9 genome-editing startup from scientific breakthrough toward the development of a potential cutting-edge medicine, slogging victoriously through a legendary patent fight , and reaching the cusp of an historic clinical trial , the well-traveled Bosley is cutting out, the company said Tuesday.

Guide 63

Guide Patents Startup Develop 63